A new postbiotic approach to metabolic balance
pA1c®HI is Genbioma’s leading postbiotic ingredient for metabolic health applications. Clinically validated, heat-stable and designed for integration into foods, beverages and nutraceutical products.
pA1c®HI is Genbioma’s leading postbiotic ingredient for metabolic health applications. Clinically validated, heat-stable and designed for integration into foods, beverages and nutraceutical products.
Glucose metabolism is a key component of metabolic health. As consumer demand grows for science-backed, non-pharmaceutical solutions, food, beverage and nutraceutical companies need ingredients that combine biological relevance, clinical evidence and formulation reliability. Microbiome science opens a new opportunity in this space. By working with specific bacterial strains and their postbiotic formats, it is possible to develop targeted nutritional solutions designed to support metabolic balance.
pA1c®HI is a clinically validated postbiotic ingredient developed from Genbioma’s proprietary Pediococcus acidilactici strain. Designed to support glucose-related metabolic health through the gut microbiome, pA1c®HI combines human validation with the technological advantages of a heat-inactivated postbiotic format.
It is stable, scalable and easy to formulate, making it suitable for next-generation metabolic health products across food, beverage and supplement categories.
Supported by human clinical studies showing impact on key metabolic makers.
Stable under pasteurization and UHT conditions.
Long shelf life and stable without cold chain.
Neutral sensory profile and easy to formulate.
Unlike probiotics, pA1c®HI does not rely on live bacteria. It is based on a heat-inactivated microbial preparation, designed to deliver microbiome-based functionality without requiring live-cell viability. This postbiotic format offers important advantages for industrial development, including greater stability, consistency and compatibility with demanding manufacturing processes. For brands and manufacturers, this means microbiome science can be integrated into a broader range of product formats without the complexity typically associated with live microorganisms.
pA1c®HI is a functional ingredient developed for foods, beverages and supplements.
Its stability and neutral sensory profile make it suitable for integration into existing formulations, helping companies develop science validated metabolic health products without adding unnecessary formulation or processing complexity.
Potential applications include capsules, gummies, functional beverages, dairy and plant-based products, powdered formats and other nutritional solutions.
pA1c®HI brings together extensive human validation in prediabetes, obesity and type 2 diabetes with the industrial advantages of a heat-inactivated postbiotic format.
Its stability, low effective dose, neutral sensory profile and compatibility with demanding processing conditions make it a versatile ingredient for food, beverage and nutraceutical innovation.
Backed by robust quality, safety and manufacturing standards, pA1c®HI helps companies create differentiated metabolic health products with a strong scientific and technological foundation.
Reglubetic®HI translates the science of pA1c®HI into a finished nutraceutical format, offering partners a ready-to-market capsule solution for metabolic health. Developed for companies looking to accelerate launch timelines without building a formulation from the ground up, Reglubetic®HI combines clinical validation, postbiotic stability and consumer convenience in a differentiated product powered by Genbioma’s leading postbiotic ingredient.
